⁍ Canada will invest up to C$214 million to help develop a domestically made COVID-19 vaccine.
⁍ It has secured up to 76 million doses of Quebec City-based Medicago’s potential vaccine.
⁍ The government will also invest up to C$18.2 million in Vancouver-based biotechnology company Precision NanoSystems Incorporated.
– Canada plans to spend $162 million to help a Quebec City-based biotech company develop a vaccine against a potentially deadly form of meningitis, Reuters reports. According to a statement from Prime Minister Justin Trudeau’s office, Canada will invest up to $162 million in Medicago to help develop a domestically made vaccine designed to fight meningitis B, as well as up to $76 million to support pre-clinical and clinical trials for another potential vaccine.
Source: https://www.reuters.com/article/health-coronavirus-canada/canada-to-invest-up-to-c214-mln-for-research-into-domestic-made-vaccines-pm-trudeau-idUST5N2FK01I